HomePRESS RELEASESCellectar Biosciences: Files investigational new drug application to evaluate I-131-CLR1404 in clinical...
Cellectar Biosciences: Files investigational new drug application to evaluate I-131-CLR1404 in clinical trials in relapsed or refractory multiple myeloma